{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zhou L"],"funding":["National Nature Science Foundation of China"],"pagination":["382-389"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10103561"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["25(2)"],"pubmed_abstract":["<h4>Aims</h4>Although several studies have proved that repeat catheter ablation is beneficial to recurrent atrial tachycardia (AT)/atrial fibrillation (AF) after AF catheter ablation, the hard endpoints of the effect of catheter ablation on recurrent AT/AF patients after AF catheter ablation remains unclear. Our study aims to compare the effect of catheter ablation and drug therapy on recurrent AT/AF patients after AF catheter ablation.<h4>Methods and results</h4>Four thousand nine hundred and thirteen consecutive patients with recurrent AT/AF after catheter ablation from the China-AF registry were enrolled. The patients were divided into two study groups: the repeat catheter ablation group and the medical therapy group. The primary endpoint is a composite of cardiovascular mortality or is"],"journal":["Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology"],"pubmed_title":["Effect of repeat catheter ablation vs. antiarrhythmic drug therapy among patients with recurrent atrial tachycardia/atrial fibrillation after atrial fibrillation catheter ablation: data from CHINA-AF registry."],"pmcid":["PMC10103561"],"funding_grant_id":["82103904"],"pubmed_authors":["Long D","Zhou L","Li C","Yu R","Sang C","Liu N","Du X","He L","Ma C","Li S","Dong J","Tang R","Wang W","Jiang C"],"additional_accession":[]},"is_claimable":false,"name":"Effect of repeat catheter ablation vs. antiarrhythmic drug therapy among patients with recurrent atrial tachycardia/atrial fibrillation after atrial fibrillation catheter ablation: data from CHINA-AF registry.","description":"<h4>Aims</h4>Although several studies have proved that repeat catheter ablation is beneficial to recurrent atrial tachycardia (AT)/atrial fibrillation (AF) after AF catheter ablation, the hard endpoints of the effect of catheter ablation on recurrent AT/AF patients after AF catheter ablation remains unclear. Our study aims to compare the effect of catheter ablation and drug therapy on recurrent AT/AF patients after AF catheter ablation.<h4>Methods and results</h4>Four thousand nine hundred and thirteen consecutive patients with recurrent AT/AF after catheter ablation from the China-AF registry were enrolled. The patients were divided into two study groups: the repeat catheter ablation group and the medical therapy group. The primary endpoint is a composite of cardiovascular mortality or is","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Feb","modification":"2025-04-04T12:43:45.829Z","creation":"2025-04-04T12:43:45.829Z"},"accession":"S-EPMC10103561","cross_references":{"pubmed":["36156137"],"doi":["10.1093/europace/euac169"]}}